New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 14, 2012
09:05 EDTCYTXCytori Therapeutics 7.02M share Spot Secondary priced at $2.85
Lazard Capital acted as sole book running manager for the offering.
News For CYTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 10, 2014
08:03 EDTCYTXCytori Therapeutics granted conditional FDA approval for Scleroderma trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use